A team of researchers at Chalmers University of Technology has found that kidney cancer cells have a quite different metabolism than other types of malignancies. The findings pave the way for new methods of diagnosing kidney cancer at an early stage, a feat that had eluded researchers earlier, and thereby fresh approaches to treatment.

University of Adelaide research has shown for the first time that grape seed can aid the effectiveness of chemotherapy in killing colon cancer cells as well as reducing the chemotherapy's side effects.

As proof-of-principle, the team designs potent anti-cancer compound.

Dartmouth researchers have developed a protocol that permits cells harvested from melanoma tumors in mice to grow readily in cell culture. Their findings were published in an article, Multiple murine BRafV600E melanoma cell lines with sensitivity to PLX4032, in the January 25, 2014 issue of Pigment Cell & Melanoma Research.

Specific compounds found in exhaled breath may help diagnose lung cancer in its early stages, according to a study released Jan. 28 at the 50th Annual Meeting of The Society of Thoracic Surgeons.

A team of researchers at the University of Toronto has discovered a method of assembling “building blocks” of gold nanoparticles as the vehicle to deliver cancer medications or cancer-identifying markers directly into cancerous tumors.

Research to focus on metastatic breast cancer.

Early Step toward Treatment for Diseases that Affect Blood Flow.

By attaching a cancer-killer protein to white blood cells, Cornell University biomedical engineers have demonstrated the annihilation of metastasizing cancer cells traveling throughout the bloodstream.

The Stanford University School of Medicine has received $90 million from Ludwig Cancer Research on behalf of its founder, Daniel K. Ludwig, to support the school's innovative work in cancer stem cells, which are believed to drive the growth of many cancers.